‘Cigna is committed to reducing opioid use: Removing OxyContin from group commercial drug lists on 1/1/18.’ America’s opioid epidemic is complex, and Cigna has taken a multi-faceted approach to reducing opioid use among its customers by 25 percent by 2019. The company’s covered drug lists are regularly evaluated with an eye to eliminating the inappropriate use…